Berkeley Lights, Inc. (BLI)
Market Cap | 167.34M |
Revenue (ttm) | 83.94M |
Net Income (ttm) | -86.47M |
Shares Out | 68.86M |
EPS (ttm) | -1.29 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 802,154 |
Open | 2.30 |
Previous Close | 2.36 |
Day's Range | 2.27 - 2.51 |
52-Week Range | 1.83 - 9.03 |
Beta | 1.45 |
Analysts | Buy |
Price Target | 10.46 (+330.45%) |
Earnings Date | Feb 23, 2023 |
About BLI
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California. [Read more]
Financial Performance
In 2021, BLI's revenue was $85.39 million, an increase of 32.79% compared to the previous year's $64.30 million. Losses were -$71.72 million, 72.5% more than in 2020.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is $10.46, which is an increase of 330.45% from the latest price.
News

SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation
NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation ("IsoPlexis" or th...

Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended Dece...

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications E...

Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif. , Jan. 3, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the Company will be participating in the upcoming 41st Annual J.P.

ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IsoPlexis Corp...

BLI STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Berkeley Lights, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Berkeley Lights, Inc. (NASDAQ: BLI) and Isoplexis Corporation is fair to Berkeley sha...

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutics Conference
EMERYVILLE, Calif. , Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Thera...

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
Enables access to a broad range of biodiversity to find unique antibodies against challenging targets EMERYVILLE, Calif. , Nov. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ: BLI), a leader i...

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform
EMERYVILLE, Calif. and MELBOURNE, Australia , Nov. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's ...

Berkeley Lights, Inc. (BLI) Reports Q3 Loss, Misses Revenue Estimates
Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -18.52% and 1.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc...

Berkeley Lights Reports Third Quarter 2022 Financial Results
EMERYVILLE, Calif. , Nov. 8, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended September 30, 2022.

Berkeley Lights to Host Upcoming Investor Day
EMERYVILLE, Calif. , Nov. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced it will host its 2022 Investor Day on Friday, November 18 start...

Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022
EMERYVILLE, Calif. , Oct. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the t...

Berkeley Lights to Participate in the BioProcess International 2022 Conference
Company to present on its Bispecifics Heterodimer Assay and Custom Productivity Assay for the Opto ® Cell Line Development workflow GSK Vaccines, Rockville to present on their successful implementati...

Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer
EMERYVILLE, Calif. , Sept. 19, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal o...

Berkeley Lights, Inc. (BLI) Reports Q2 Loss, Misses Revenue Estimates
Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -26.67% and 14.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Berkeley Lights Reports Second Quarter 2022 Financial Results
Company outlines near-term strategic plan to generate positive operating cashflow by early 2025 EMERYVILLE, Calif. , Aug. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digit...

Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen
EMERYVILLE, Calif. , Aug. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today a...

Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference
Presentation to feature the Company's soon-to-be launched bispecific and custom productivity assay for the Opto® Cell Line Development workflow EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Berkel...

Berkeley Lights Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development
EMERYVILLE, Calif. , Aug. 1, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Rolando Brawer, Ph.D.

Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide
Using Berkeley Lights' high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE,...

Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer
EMERYVILLE, Calif. , July 25, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO),...

Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022
EMERYVILLE, Calif. , July 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the s...

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform Lonza and Edinburgh Genome Foundry to present their high-through...

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
EMERYVILLE, Calif. & ALBANY, N.Y.--(BUSINESS WIRE)-- #AMRI--Curia now provides a comprehensive portfolio of state-of-the-art technologies and experience for rapid progression of client antibody progra...